In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report exploring pre-cervical cancer and CIN.
MTM Laboratories Can Detect The Earliest Stages of Cervical Cancer
MTM Laboratories has developed a proprietary technological platform that has identified a novel biomarker that serves for the early detection of cervical cancer.
Photocure Develops a Non-surgical Treatment For HPV
A new non-surgical, tissue-preserving therapeutic procedure is being developed to more effectively remove HPV infection and treat precursors of cervical cancer.
Ovatech Leaves the Hormones Out of Birth Control
Ovatech of Auburndale, Mass., is developing the world’s first non-hormonal, female-controlled contraception device.
For Advaxis, Bacteria Help More Than They Hurt
The idea of using harmful bacteria to treat disease might strike many as an odd concept.
The Universal Vaccines of Inovio Biomedical
Inovio is developing a universal flu vaccine engineered to prevent several strains of influenza at once.
Guided Therapeutics Study Reveals Cervical Screening Shortcomings
A clinical trial by Guided Therapeutics (GT), a biotechnology company specializing in women’s health, found that current screening methods for cervical disease missed the disease nearly a third of the time.
